Connect with us
The American pharmaceutical company Bristol is crowned as the most innovative company in the health sector and occupies the eighteenth position in the global ranking. The...
The total shareholder return in 2020 was 19.3% in CHF and 18.1% in EUR, slightly below the performance of the underlying portfolio. In addition to Mersana...
More and more people are getting cancer. In Germany alone, doctors diagnose around half a million new cancer patients every year. But science is also making...
With a plan of building a premier innovative biopharma company and now a highly diversified portfolio, Bristol-Myers Squibb’s merger deal with Celgene is expected to become...